.After having a look at phase 1 record, Nuvation Bio has made a decision to halt deal with its own s...
.Zevra Therapies' unusual ailment medicine seems to become on the path to authorization this fall af...
.Pfizer's period 3 Duchenne muscle dystrophy (DMD) genetics therapy failing has actually blown a $23...
.After greater than twenty years of service neurodegenerative diseases, Swiss biotech air conditione...
.GSK has broken up a phase 2 human papillomavirus (HPV) vaccine from its pipe after making a decisio...
.Operating system Therapies will specify on the NYSE American supply substitution today using a $6.4...
.ALX Oncology's period 2 stomach cancer cells action cost has actually weakened. After observing its...
.Yet Another of Ionis Pharmaceuticals' vital midphase readouts has actually disappointed assumptions...
.While Biogen's pharma peers are looking for late-stage properties along with little threat, CEO Chr...
.Instil Biography has been a biotech trying to find a pipe after it ditched its own lead resources o...